Ex-SignalFire investor raised $27.5 million for debut fund Proximal Ventures, betting on AI in drug development
Sahir Ruof, previously at SignalFire, Iterative Health and Flatiron Health, founded the venture firm Proximal Ventures and closed its first fund at $27.5 million. The fund invests $500,000 to $1.5 million in pre-seed and seed startups that apply AI to services for the pharmaceutical industry — from synthesizing compounds to analyzing clinical trial data. Backers include SignalFire, Kleiner Perkins and former FDA official Amy Abernethy.
Otabek Yusupov